NSE - Delayed Quote INR

Balaxi Pharmaceuticals Limited (BALAXI.NS)

51.75

-0.94

(-1.78%)

At close: May 9 at 3:29:41 PM GMT+5:30

Stock market today: Dow, S&P 500, Nasdaq futures surge as markets cheer US-China trade talks

Wall Street reacted positively to the news of US-China trade talks approaching a place of 'progress.'

Yahoo Finance 1 hour ago

ES=F

YM=F

NQ=F
Walmart, Deere, Alibaba, Cisco: Earnings to Watch This Week

Asking for a Trend Josh Lipton looks ahead to this week as he previews several of the biggest earnings reports that Wall Street will have its eyes on, including Walmart (WMT), Alibaba (BABA), Cisco Systems (CSCO), Deere & Co. (DE), and CoreWeave (CRWV). To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend here.

Yahoo Finance Video 14 hours ago

DE

CAVA

BABA
U.S.-China Talks End: Bessent Touts 'Substantial Progress'; White House Signals Deal

Treasury Secretary Scott Bessent cited "substantial progress" after weekend China trade talks, with more details Monday.

Investor's Business Daily 2 hours ago

WMT

BABA

BABAF
The Best Stocks to Invest $1,000 in Right Now

Major benchmarks are down this year amid concerns about import tariffs and their impact on economic growth. The stock market may not seem like the friendliest place for investors right now, with the three major benchmarks -- the S&P 500, the Dow Jones Industrial Average, and the Nasdaq Composite -- down since the start of the year. Worries about President Donald Trump's plan to impose tariffs on imports have halted the positive momentum that carried indexes over the past two years.

Motley Fool 4 hours ago

NVDA

TGT

AMZN
Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

Lilly reported in December that its obesity drug had already met the main goal, leading to 47% more weight loss than those who received Wegovy. The data is the first head-to-head trial comparing the wildly popular medicines, and gives Lilly more firepower as it seeks to gain wider insurance coverage in an obesity drug market estimated to reach more than $150 billion annually by the next decade.

Reuters 4 hours ago

LLY

NVO
Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine

Eli Lilly and Company (NYSE: LLY) today announced detailed results from SURMOUNT-5, a Phase 3b open-label clinical trial, evaluating the safety and efficacy of Zepbound (tirzepatide), a dual GIP and GLP-1 receptor agonist, compared to Wegovy (semaglutide), a mono GLP-1 receptor agonist, in adults living with obesity, or overweight with at least one weight-related medical problem and without diabetes. At 72 weeks, Zepbound met the primary endpoint and all five key secondary endpoints, demonstrati

PR Newswire 4 hours ago

LLY
Alibaba Group Holding (BABA): Among Michael Burry Stocks with Huge Upside Potential

We recently published a list of 10 Michael Burry Stocks with Huge Upside Potential. In this article, we are going to take a look at where Alibaba Group Holding Limited (NYSE:BABA) stands against other Michael Burry stocks with huge upside potential. Michael Burry, founder and manager of Scion Asset Management, is best known for predicting and […]

Insider Monkey 5 hours ago

BABA
Is Apple Inc. (AAPL) the Best Stock to Buy According to Jim Simons’ Renaissance Technologies?

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we are going to take a look at where Apple Inc. (NASDAQ:AAPL) stands against other best stocks to buy according to Jim Simons’ Renaissance Technologies. Even after his passing in 2024, billionaire investor and mathematician […]

Insider Monkey 5 hours ago

AAPL
NVIDIA Corporation (NVDA): Among the Best Stocks to Buy According to Jim Simons’ Renaissance Technologies

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we are going to take a look at where NVIDIA Corporation (NASDAQ:NVDA) stands against other best stocks to buy according to Jim Simons’ Renaissance Technologies. Even after his passing in 2024, billionaire investor and mathematician […]

Insider Monkey 5 hours ago

NVDA
Tesla, Inc. (TSLA): Among the High Growth EV Stocks to Invest In

We recently compiled a list of the 10 High Growth EV Stocks to Invest In. In this article, we are going to take a look at where Tesla, Inc. (NASDAQ:TSLA) stands against the other best High Growth EV stocks. Automobiles that run on electricity rather than gas are referred to as electric cars, or EVs. Electric […]

Insider Monkey 5 hours ago

TSLA
Should You Buy Nvidia Before May 19?

Nvidia is a favorite among customers building artificial intelligence platforms, which has helped the stock soar. In recent weeks, though, Nvidia shares have slipped amid import tariffs and economic worries. Investors will be on the lookout for Nvidia news on May 19.

Motley Fool 6 hours ago

NVDA
AI Stocks Face 'Show Me' Moment. CoreWeave Earnings On Tap.

Amid hype over artificial intelligence, the best AI stocks generate revenue or get a strategic edge from the fast evolving technology.

Investor's Business Daily 7 hours ago

ADBE

NVDA
1 Stock to Buy, 1 Stock to Sell This Week: Alibaba, Walmart

U.S. stocks ended the week on a quiet note on Friday to cap a losing week, as investors awaited much-anticipated talks between U.S. and China officials on trade and economic issues.

Investing.com 8 hours ago

WMT

BABA

COMP
Onto Innovation (NYSE:ONTO) Reports Robust Q1 2025 Earnings with Increased Sales

Onto Innovation (NYSE:ONTO) recently announced robust first-quarter 2025 earnings, with a significant year-over-year increase in sales and net income, along with positive guidance for the second quarter. Despite these strong financials, the company's stock experienced a 26% decline over the past month. This negative price movement seems disconnected from Onto's promising performance, especially as the broader market remained flat during the same period. The juxtaposition of Onto's earnings...

Simply Wall St. 9 hours ago

ONTO
Tesla Vs. BYD: TSLA Flashes Aggressive Entry While Rival Nears Buy Point

Tesla has topped an early entry while BYD stock is near a base buy point. BYD growth is booming while TSLA investors bet on robotaxis.

Investor's Business Daily 9 hours ago

TSLA

BYDDY
Prediction: This Artificial Intelligence (AI) Semiconductor Stock Will Soar After May 28

Most of the major players in the AI landscape have already delivered their Q1 earnings reports -- but Nvidia's results are still to come.

Motley Fool 9 hours ago

NVDA

AMD

META
Buy Chipotle Mexican Grill on the Sell-Off? Or Is This Growth Machine a Better Choice?

Chipotle Mexican Grill has hit a weak patch, for the business and the stock. Wingstop is growing its business rapidly and revenue is still expanding quickly. Wingstop's business model is drastically different from Chipotle Mexican Grill's model.

Motley Fool 10 hours ago

CMG

WING
Here's Why I'm Not Too Worried for Alphabet Despite Apple's Potential New AI-Powered Safari Search

Investors panicked when the possibility was floated, but take a step back and look at the bigger picture.

Motley Fool 11 hours ago

GOOG

AAPL
Rivian: Should You Buy the Stock Before Its Next Big Milestone?

Rivian reached another big milestone, turning a gross profit for the second straight quarter. The electric vehicle maker is looking to advance its higher-margin software platform. Rivian Automotive (NASDAQ: RIVN) reached a big milestone when it reported its first-quarter results, producing a gross profit for the second consecutive quarter.

Motley Fool 13 hours ago

RIVN

TSLA
Stock Splits Revisited: Here's How 3 High-Profile Stocks Have Performed Since Their Splits.

Nvidia has grown revenue, net income, and earnings per share around 35% over the last year. Markets have cheered Broadcom's first-ever stock split. Investors should blame a steep valuation for Palo Alto Networks' post-split slide.

Motley Fool 14 hours ago

NVDA

AVGO

PANW

Performance Overview

Return	BALAXI.NS	S&P BSE SENSEX (^BSESN)
YTD	-28.43%	+1.68%
1-Year	-57.08%	+9.74%
3-Year	-41.75%	+45.87%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Balaxi Pharmaceuticals Limited (BALAXI.NS)

Related News

Stock market today: Dow, S&P 500, Nasdaq futures surge as markets cheer US-China trade talks

Walmart, Deere, Alibaba, Cisco: Earnings to Watch This Week

U.S.-China Talks End: Bessent Touts 'Substantial Progress'; White House Signals Deal

The Best Stocks to Invest $1,000 in Right Now

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine

Alibaba Group Holding (BABA): Among Michael Burry Stocks with Huge Upside Potential

Is Apple Inc. (AAPL) the Best Stock to Buy According to Jim Simons’ Renaissance Technologies?

NVIDIA Corporation (NVDA): Among the Best Stocks to Buy According to Jim Simons’ Renaissance Technologies

Tesla, Inc. (TSLA): Among the High Growth EV Stocks to Invest In

Should You Buy Nvidia Before May 19?

AI Stocks Face 'Show Me' Moment. CoreWeave Earnings On Tap.

1 Stock to Buy, 1 Stock to Sell This Week: Alibaba, Walmart

Onto Innovation (NYSE:ONTO) Reports Robust Q1 2025 Earnings with Increased Sales

Tesla Vs. BYD: TSLA Flashes Aggressive Entry While Rival Nears Buy Point

Prediction: This Artificial Intelligence (AI) Semiconductor Stock Will Soar After May 28

Buy Chipotle Mexican Grill on the Sell-Off? Or Is This Growth Machine a Better Choice?

Here's Why I'm Not Too Worried for Alphabet Despite Apple's Potential New AI-Powered Safari Search

Rivian: Should You Buy the Stock Before Its Next Big Milestone?

Stock Splits Revisited: Here's How 3 High-Profile Stocks Have Performed Since Their Splits.

Performance Overview